Prot# C.2004.140: A Multi-Centered, Prospective, Randomized, Placebo-Controlled Clinical Trial for The Treatment of Significant Steatosis or NASH with Xenical Followed by Treatment of Hepatitis C (HCV) with PEG-Interferon alpha-2a/Copegus

Project: Research project

Project Details

StatusFinished
Effective start/end date10/24/0510/24/10

Funding

  • Geneva Foundation (C.2004.140)
  • Roche Laboratories Inc. (C.2004.140)